Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/39700, first published .
Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial

Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial

Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial

Journals

  1. Assefa D, Tesefaye T, Bekele E, Geberemickeal G, Mebratu A, Ejigu A, Nigatu T, Zeleke E. Active surveillance of immunization adverse effects: a multicentre, open-label, three-arm randomized uncontrolled trial in Ethiopia. International Health 2025;17(2):195 View
  2. Malden D, Gee J, Glenn S, Li Z, Ryan D, Gu Z, Bezi C, Kim S, Jazwa A, McNeil M, Weintraub E, Tartof S. A Texting- and Internet-Based Self-Reporting System for Enhanced Vaccine Safety Surveillance With Insights From a Large Integrated Health Care System in the United States: Prospective Cohort Study. JMIR mHealth and uHealth 2024;12:e58991 View
  3. Gauna F, Raude J, Khouri C, Cracowski J, Ward J. Exploring the relationship between experience of vaccine adverse events and vaccine hesitancy: A scoping review. Human Vaccines & Immunotherapeutics 2025;21(1) View